US6160196A - Antimicrobial wound coverings - Google Patents

Antimicrobial wound coverings Download PDF

Info

Publication number
US6160196A
US6160196A US08/910,441 US91044197A US6160196A US 6160196 A US6160196 A US 6160196A US 91044197 A US91044197 A US 91044197A US 6160196 A US6160196 A US 6160196A
Authority
US
United States
Prior art keywords
wound
wound covering
hydrophobic
active compound
threads
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/910,441
Inventor
Roland Knieler
Axel von Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TJ Smith and Nephew Ltd
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Assigned to BEIERSDORF AG reassignment BEIERSDORF AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KNIELER, ROLAND, VON WOLFF, AXEL
Application granted granted Critical
Publication of US6160196A publication Critical patent/US6160196A/en
Assigned to T J SMITH & NEPHEW LIMITED reassignment T J SMITH & NEPHEW LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BEIERSDORF AG
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/022—Adhesive bandages or dressings with fluid retention members having more than one layer with different fluid retention characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0226—Adhesive bandages or dressings with fluid retention members characterised by the support layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Definitions

  • the invention relates to wound coverings which can be employed for treatment of infected wounds or for preventive protection against wound infections.
  • oxidizing agents for example iodine tincture
  • antiseptics for example ointments comprising silver sulphadiazine
  • the action mechanism is always comparable.
  • Microorganisms such as bacteria are indeed reliably destroyed.
  • a number of disadvantages remain to be mentioned: Bacteria which have died remain in the wound. Wounds cannot be cleaned to remove the active compound reliably after the application, since it spreads in the entire wound. Finally, if these active compounds occur freely in the wound, they can also attack and destroy cells and substances in the wound fluid which promote wound healing (for example damage to healing-promoting protein substances by oxidizing agents).
  • wounds with antimicrobially treated wound coverings.
  • These wound coverings can be prepared, for example, by treatment of carriers such as woven fabrics, nonwovens, gauze and the like with active compounds.
  • active compounds such as woven fabrics, nonwovens, gauze and the like.
  • the wound covering merely forms a barrier for microorganisms which are prevented from penetrating into the wound from the outside by being destroyed on contact with the product. The action in the wound is negligible here. It therefore cannot be regarded as treatment of an infected wound.
  • the active compound is released from antimicrobially treated wound coverings into the wound, the same disadvantages arise as with application in an extra pure form, as a solution, as an ointment or in another presentation form. That is to say, the bacteria remain in the wound, no reliable cleaning of the wound is possible and troublesome effects may occur.
  • hydrophobized carrier materials In addition to the two most widely used treatment methods described above, that is to say application of antimicrobial formulations and the use of impregnated wound treatment materials, the use of hydrophobized carrier materials is also described (EP-B 021 230, EP-B 162 026 and EP-A 296 441).
  • hydrophobic bacteria are adsorbed by a wound covering, which has been hydrophobized by an involved chemical process, in a hydrophilic medium (water, salt solution or wound fluid). The bacteria are then withdrawn from the wound by removal of the wound covering.
  • a decisive disadvantage here is that, in contrast to the customary treatment methods mentioned above, bacteria and microorganisms are not destroyed. This disadvantage is intensified further if the treated wound dries out. This means the loss of the hydrophilic medium, which contributes decisively to the interaction between the wound covering and bacteria. The bacteria and microrganisms which have not been destroyed become detached from the wound covering and fall back into the wound bed.
  • the object of the invention was therefore to develop a wound covering which does not have the disadvantages of the prior art and renders possible an improved treatment of infected wounds and/or protection against infections. This object is achieved by a wound covering according to claim 1.
  • the wound covering serves as a barrier for microorganisms and it adsorbs the bacteria from the wound fluid. After the adsorption, these bacteria are destroyed on the wound covering, and the destroyed bacteria and unused active compound are likewise removed with the removal of the covering. They therefore no longer interfere with the healing process.
  • Suitable bacteria-adsorbing hydrophobic materials can be synthetic or naturally occurring or chemically modified naturally occurring polymers, such as polyethylene, polypropylene, polyurethane, polyamide, polyester, polyvinyl chloride, polytetrafluoroethylene or polymers which are prepared by covalent linking of hydrophilic substances with hydrophobic groups, for example according to EP-B 21 230.
  • the bacteria-adsorbing properties of hydrophobic materials are known (cf. D. F. Gerson et al., Biochim. Biophys. Acta, 602 (1980, 506-510); Y. Fujioka-Hirai. et al., J. of Biochemical Materials Research, Volume 21, 913-20 (1987); S. Hjerten et al., J.
  • the hydrophobic properties can also be detected easily by a water drop test, in which the water beads on the material.
  • Suitable antimicrobial active compounds which are primarily to be understood as meaning substances which are known per se, such as, for example, chlorhexidine or phenol derivatives, such as thymol and eugenol, or the chlorophenols or chlorodiphenyl ethers known in DE-PS 32 15 134, are distinguished by the fact that they adhere firmly to the wound covering, act on or in this on the microorganisms and are not released, or at least are not released noticeably, into the wound. This can be effected by physical incorporation into or addition onto suitable carriers, for example incorporation of hydrophobic active compounds into hydrophobic carrier materials or, for example, also by covalent bonding to these.
  • the active compound/carrier systems should be distinguished by the fact that their antimicrobial activity is retained even during several extractions with aqueous solutions or wound fluid.
  • the wound coverings should comprise the antimicrobial active compound in an amount of at least 0.001% by weight in order to achieve an adequate activity. This amount is preferably 0.1-10%, particularly preferably 0.1-2% by weight.
  • antimicrobial active compounds adhere firmly to the wound covering, they should nevertheless not be toxic or irritating to the skin, in order to exclude any negative action on the patient.
  • wound coverings according to the invention which as a rule are in the form of more or less thin sheet-like structures, can be made of a hydrophobic material in the form of a woven fabric, knitted fabric, net, nonwoven, foam or a film, which comprises the antimicrobial active compound in or on it.
  • they can be made of a nonwoven, woven fabric, knitted fabric or net with on the one hand hydrophobic fibres or threads and on the other hand fibres or threads which comprise the active compound. They can also be built up from mixed threads which are made of hydrophobic fibres and antimicrobially active fibres.
  • wound coverings overall have a significantly hydrophobic character.
  • the antimicrobial fibres are acetate fibres, which particularly preferably comprise a chlorinated phenoxy bactericide.
  • Such fibres are commercially obtainable as MICROSAFE fibres.
  • Another possibility for building up the wound covering comprises bonding the hydrophobic fibres by a binder which comprises the antimicrobial agent.
  • the wound coverings should be permeable to air and water vapour. However, since they can absorb essentially no wound secretion per se, it may prove to be advantageous to render them more permeable, for example by perforation, and then to deposit an absorbent layer on them. In the case of wounds which must not dry out, so-called hydroactive wound dressings or wound dressings based on hydrogels can be positioned over the permeable wound covering.
  • these can also be bonded, for example, on the side facing away from the wound, to a projecting carrier material which has been given a self-adhesive treatment.
  • the side facing the wound is then usually provided with a protective covering, for example of siliconized paper.
  • a knitted fabric (a tricot warp knitted fabric with a weight per unit area of 170 g/m 2 ) is produced from a thread which is composed of polyester fibres to the extent of 80% and Microsafe AM® fibres to the extent of 20%.
  • the knitted fabric is sterilized and employed as a wound covering under a hydroactive wound dressing (for example in accordance with WO 94/07935).
  • Polypropylene fibres are bonded to a nonwoven with Microsafe AM® fibres from Hoechst Celanese (thickness 0.5 mm, 50 g/m 2 , 90% by weight of polypropylene fibres, 10% by weight of Microsafe AM® fibres).
  • the nonwoven is used as a wound covering with a commercially available fixing.
  • a hydrophobic polyurethane film based on an aliphatic polyester-urethane is produced by a dispersion casting process (thickness 80 ⁇ m).
  • thickness 80 ⁇ m By addition of an appropriate amount of thymol (2-isopropyl-5-methylphenol) to the aqueous dispersion, the film comprises 0.1% by weight of thymol.
  • the film is perforated (diameter of the holes: 1 mm, perforated area 15%). The film is then sterilized and employed as a wound covering under a hydroactive wound dressing.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Wound covering which is characterized in that it is made of a hydrophobic bacteria-adsorbing material which comprises an antimicrobial active compound which is not released into the wound. It is preferably made of a mixture of hydrophobic fibres and fibres comprising the antimicrobial active compound.

Description

The invention relates to wound coverings which can be employed for treatment of infected wounds or for preventive protection against wound infections.
Antimicrobial treatment of wounds or preventive treatment of wounds to protect them against infections by microorganisms have been known for a long time. The use of oxidizing agents (for example iodine tincture) or antiseptics (for example ointments comprising silver sulphadiazine) may be mentioned here by way of example. If oxidizing agents or other antimicrobial active compounds are employed in an extra pure form, in solution, as an ointment or in another presentation form, the action mechanism is always comparable. Microorganisms such as bacteria are indeed reliably destroyed. However, a number of disadvantages remain to be mentioned: Bacteria which have died remain in the wound. Wounds cannot be cleaned to remove the active compound reliably after the application, since it spreads in the entire wound. Finally, if these active compounds occur freely in the wound, they can also attack and destroy cells and substances in the wound fluid which promote wound healing (for example damage to healing-promoting protein substances by oxidizing agents).
One of the next steps in wound treatment was to cover wounds with antimicrobially treated wound coverings. These wound coverings can be prepared, for example, by treatment of carriers such as woven fabrics, nonwovens, gauze and the like with active compounds. By covering wounds with these products which do not release the active compound, however, as a rule only a protective function is achieved. The wound covering merely forms a barrier for microorganisms which are prevented from penetrating into the wound from the outside by being destroyed on contact with the product. The action in the wound is negligible here. It therefore cannot be regarded as treatment of an infected wound.
If the active compound is released from antimicrobially treated wound coverings into the wound, the same disadvantages arise as with application in an extra pure form, as a solution, as an ointment or in another presentation form. That is to say, the bacteria remain in the wound, no reliable cleaning of the wound is possible and troublesome effects may occur.
In addition to the two most widely used treatment methods described above, that is to say application of antimicrobial formulations and the use of impregnated wound treatment materials, the use of hydrophobized carrier materials is also described (EP-B 021 230, EP-B 162 026 and EP-A 296 441). In this case, hydrophobic bacteria are adsorbed by a wound covering, which has been hydrophobized by an involved chemical process, in a hydrophilic medium (water, salt solution or wound fluid). The bacteria are then withdrawn from the wound by removal of the wound covering. A decisive disadvantage here is that, in contrast to the customary treatment methods mentioned above, bacteria and microorganisms are not destroyed. This disadvantage is intensified further if the treated wound dries out. This means the loss of the hydrophilic medium, which contributes decisively to the interaction between the wound covering and bacteria. The bacteria and microrganisms which have not been destroyed become detached from the wound covering and fall back into the wound bed.
The object of the invention was therefore to develop a wound covering which does not have the disadvantages of the prior art and renders possible an improved treatment of infected wounds and/or protection against infections. This object is achieved by a wound covering according to claim 1.
By the combination according to the invention of a hydrophobic and therefore bacteria-adsorbing material and an antimicrobial active compound which is not released into the wound, a new action mechanism with a synergistic effect is achieved.
The wound covering serves as a barrier for microorganisms and it adsorbs the bacteria from the wound fluid. After the adsorption, these bacteria are destroyed on the wound covering, and the destroyed bacteria and unused active compound are likewise removed with the removal of the covering. They therefore no longer interfere with the healing process.
Suitable bacteria-adsorbing hydrophobic materials can be synthetic or naturally occurring or chemically modified naturally occurring polymers, such as polyethylene, polypropylene, polyurethane, polyamide, polyester, polyvinyl chloride, polytetrafluoroethylene or polymers which are prepared by covalent linking of hydrophilic substances with hydrophobic groups, for example according to EP-B 21 230. The bacteria-adsorbing properties of hydrophobic materials are known (cf. D. F. Gerson et al., Biochim. Biophys. Acta, 602 (1980, 506-510); Y. Fujioka-Hirai. et al., J. of Biochemical Materials Research, Volume 21, 913-20 (1987); S. Hjerten et al., J. of Chromatography 101 (1974), 281-288; M. Fletcher et al., Appl. and Environmental Microbiology, January 1979, 67-72). The hydrophobic properties can also be detected easily by a water drop test, in which the water beads on the material.
Suitable antimicrobial active compounds, which are primarily to be understood as meaning substances which are known per se, such as, for example, chlorhexidine or phenol derivatives, such as thymol and eugenol, or the chlorophenols or chlorodiphenyl ethers known in DE-PS 32 15 134, are distinguished by the fact that they adhere firmly to the wound covering, act on or in this on the microorganisms and are not released, or at least are not released noticeably, into the wound. This can be effected by physical incorporation into or addition onto suitable carriers, for example incorporation of hydrophobic active compounds into hydrophobic carrier materials or, for example, also by covalent bonding to these. The active compound/carrier systems should be distinguished by the fact that their antimicrobial activity is retained even during several extractions with aqueous solutions or wound fluid. The wound coverings should comprise the antimicrobial active compound in an amount of at least 0.001% by weight in order to achieve an adequate activity. This amount is preferably 0.1-10%, particularly preferably 0.1-2% by weight.
Although the antimicrobial active compounds adhere firmly to the wound covering, they should nevertheless not be toxic or irritating to the skin, in order to exclude any negative action on the patient.
The wound coverings according to the invention, which as a rule are in the form of more or less thin sheet-like structures, can be made of a hydrophobic material in the form of a woven fabric, knitted fabric, net, nonwoven, foam or a film, which comprises the antimicrobial active compound in or on it.
In another embodiment, they can be made of a nonwoven, woven fabric, knitted fabric or net with on the one hand hydrophobic fibres or threads and on the other hand fibres or threads which comprise the active compound. They can also be built up from mixed threads which are made of hydrophobic fibres and antimicrobially active fibres.
It is important here that the wound coverings overall have a significantly hydrophobic character.
In a preferred embodiment, the antimicrobial fibres are acetate fibres, which particularly preferably comprise a chlorinated phenoxy bactericide. Such fibres are commercially obtainable as MICROSAFE fibres.
Another possibility for building up the wound covering comprises bonding the hydrophobic fibres by a binder which comprises the antimicrobial agent.
The wound coverings should be permeable to air and water vapour. However, since they can absorb essentially no wound secretion per se, it may prove to be advantageous to render them more permeable, for example by perforation, and then to deposit an absorbent layer on them. In the case of wounds which must not dry out, so-called hydroactive wound dressings or wound dressings based on hydrogels can be positioned over the permeable wound covering.
To fix the coverings, these can also be bonded, for example, on the side facing away from the wound, to a projecting carrier material which has been given a self-adhesive treatment. The side facing the wound is then usually provided with a protective covering, for example of siliconized paper.
The antimicrobial wound coverings according to the invention--if appropriate combined with other materials as described--are cut or stamped into the desired formats, sealed and sterilized, depending on the envisaged intended use.
The following examples are intended to illustrate the invention by way of example.
EXAMPLE 1
A knitted fabric (a tricot warp knitted fabric with a weight per unit area of 170 g/m2) is produced from a thread which is composed of polyester fibres to the extent of 80% and Microsafe AM® fibres to the extent of 20%. The knitted fabric is sterilized and employed as a wound covering under a hydroactive wound dressing (for example in accordance with WO 94/07935).
EXAMPLE 2
Polypropylene fibres are bonded to a nonwoven with Microsafe AM® fibres from Hoechst Celanese (thickness 0.5 mm, 50 g/m2, 90% by weight of polypropylene fibres, 10% by weight of Microsafe AM® fibres). The nonwoven is used as a wound covering with a commercially available fixing.
EXAMPLE 3
A hydrophobic polyurethane film based on an aliphatic polyester-urethane is produced by a dispersion casting process (thickness 80 μm). By addition of an appropriate amount of thymol (2-isopropyl-5-methylphenol) to the aqueous dispersion, the film comprises 0.1% by weight of thymol. The film is perforated (diameter of the holes: 1 mm, perforated area 15%). The film is then sterilized and employed as a wound covering under a hydroactive wound dressing.

Claims (10)

What is claimed is:
1. A wound covering comprising a hydrophobic, bacteria-absorbing synthetic or naturally-occurring polymeric fiber material, having adhered thereto an antimicrobial active compound which is adapted to not be released into the wound.
2. Wound covering according to claim 1, wherein the hydrophobic material is present in the form of a woven fabric, knitted fabric, net, or a nonwoven which comprises the antimicrobial active compound.
3. Wound covering according to claim 1, wherein, said material is a nonwoven, woven fabric, knitted fabric or net of hydrophobic fibers or threads and fibers or threads which comprise the antimicrobial active compound.
4. Wound covering according to claim 1, wherein said material is a nonwoven, woven fabric, knitted fabric or net with mixed threads of hydrophobic fibers which comprise the antimicrobial active compound.
5. Wound covering according to claim 3, wherein the fibers or threads comprising the antimicrobial active compound are acetate fibers or threads.
6. Wound covering according claim 1, wherein said wound covering is permeable to water.
7. Wound covering according to claim 6, in combination with an absorbent covering placed behind said wound covering.
8. Wound covering according to claim 6, in combination with a moisture-donating covering placed behind said wound covering.
9. Wound covering according to claim 1, wherein said wound covering is covered, on the side facing away from the wound, with a carrier material which projects beyond the wound covering and has been given a self-adhesive treatment.
10. The wound covering of claim 1, wherein said polymeric fiber is a fiber of a polymer selected from the group consisting of polyethylene, polypropylene, polyurethane, polyamide, polyester, polyvinyl chloride, polytetrafluoroethylene and polymers which are prepared by covalent linking of hydrophilic substances with hydrophobic groups.
US08/910,441 1996-08-06 1997-08-05 Antimicrobial wound coverings Expired - Fee Related US6160196A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19631421A DE19631421C2 (en) 1996-08-06 1996-08-06 Antimicrobial wound dressings
DE19631421 1996-08-06

Publications (1)

Publication Number Publication Date
US6160196A true US6160196A (en) 2000-12-12

Family

ID=7801720

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/910,441 Expired - Fee Related US6160196A (en) 1996-08-06 1997-08-05 Antimicrobial wound coverings

Country Status (4)

Country Link
US (1) US6160196A (en)
EP (1) EP0826348A3 (en)
AU (1) AU716910B2 (en)
DE (1) DE19631421C2 (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US6712121B2 (en) 2001-10-12 2004-03-30 Kimberly-Clark Worldwide, Inc. Antimicrobially-treated fabrics
US20040082925A1 (en) * 2002-10-23 2004-04-29 Patel Harish A. Medical dressing containing antimicrobial agent
US20040092896A1 (en) * 2002-11-13 2004-05-13 Thompson Kaila R. Antimicrobial sheets for environmental and human protection
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20050035327A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Topical silver-based antimicrobial composition for wound care devices
US20050037057A1 (en) * 2003-08-14 2005-02-17 Schuette Robert L. Silver-containing antimicrobial fabric
US20050037680A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Silver-containing wound care device
US20050147657A1 (en) * 2003-08-14 2005-07-07 Milliken & Company White silver-containing wound care device
US20050186259A1 (en) * 2004-02-25 2005-08-25 Uki Supreme Corporation Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
US20050214350A1 (en) * 2004-03-29 2005-09-29 Thompson Kaila R Antimicrobial sheets for environmental and human protection and prevention
US7045673B1 (en) 1998-12-08 2006-05-16 Quick-Med Technologies, Inc. Intrinsically bactericidal absorbent dressing and method of fabrication
US20060127462A1 (en) * 2003-08-14 2006-06-15 Canada T A Wound care device having fluid transfer properties
US20060129080A1 (en) * 2004-12-10 2006-06-15 Bjornberg Sten G Wound dressing with a bacterial adsorbing composition
US7118761B2 (en) 2003-08-14 2006-10-10 Canada T Andrew Method for producing a silver-containing wound care device
US20070189214A1 (en) * 2006-01-18 2007-08-16 Samsung Electronics Co., Ltd. Apparatus and method for transmitting/receiving signal in a communication system
US20070255192A1 (en) * 2006-04-11 2007-11-01 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
KR100791039B1 (en) 2006-07-28 2008-01-03 (재)대구경북과학기술연구원 Nano non-woven containing antioxidant for wound dressing and method for preparing thereof
WO2008088281A1 (en) * 2007-01-18 2008-07-24 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
US20090131909A1 (en) * 2007-11-05 2009-05-21 Sten Bjornberg Device for the treatment of vaginal fungal infection
US20100030178A1 (en) * 2008-08-01 2010-02-04 Macmeccan Robert M Composite article suitable for use as a wound dressing
US20100055437A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
US20100062044A1 (en) * 2008-09-11 2010-03-11 Smith Jan G Method and a product to reduce and treat problems associated with tinea pedis
US20100160853A1 (en) * 2008-12-03 2010-06-24 Smith Jan G Method for dressing a wound
US20110159051A1 (en) * 2007-05-01 2011-06-30 Taipei Veterans General Hospital Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof
US7989674B2 (en) 1997-09-22 2011-08-02 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US8093444B2 (en) 1997-09-22 2012-01-10 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US8118791B2 (en) 1995-09-05 2012-02-21 Argentum Medical, Llc Medical device
US8283513B2 (en) 1995-09-05 2012-10-09 Argentum Medical, Llc Multilayer wound dressing
US8318615B1 (en) * 1999-11-10 2012-11-27 Tri-Sis Inc. Launderable, leak-proof, breathable fabric and articles made therefrom
US8449514B2 (en) * 1997-09-22 2013-05-28 Argentum Medical, Llc Conductive wound dressings and methods of use
US20140012102A1 (en) * 2012-09-11 2014-01-09 Zansors Llc Wearable patch comprising multiple separable adhesive layers
US20140194824A1 (en) * 2013-01-08 2014-07-10 Bsn Medical Gmbh Antimicrobially active wound dressing for catheter fixings
EP3090763A1 (en) 2015-05-04 2016-11-09 IME GmbH Wound covering material
US10058455B2 (en) 2013-06-10 2018-08-28 Ultramend, Inc. Nano-enhanced wound dressing
CN110623791A (en) * 2019-10-30 2019-12-31 季华实验室 Fiber film layer and adhesive bandage with same
US12006338B2 (en) 2019-10-18 2024-06-11 Topikos Scientific, Inc. Antimicrobial organosilanes

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
DE19813663A1 (en) * 1998-03-27 1999-10-07 Beiersdorf Ag Wound dressings for removing disruptive factors from wound fluid
DE19825499C2 (en) * 1998-06-08 2003-07-17 Beiersdorf Ag Patches containing active ingredients
DE19958458A1 (en) * 1999-12-03 2001-06-21 Beiersdorf Ag Antimicrobial wound dressings
US8679523B2 (en) 1999-12-30 2014-03-25 Kimberly-Clark Worldwide, Inc. Oxygen-delivery closed cell foam matrix for wound treatment
DE10122753A1 (en) * 2001-05-12 2002-11-14 Creavis Tech & Innovation Gmbh Antimicrobial fibers and fabrics
CN1678277B (en) 2002-07-29 2010-05-05 艾克里麦德公司 Methods and compositions for treatment of dermal conditions
DE102004001594B4 (en) * 2004-01-09 2006-09-21 Bio-Gate Ag Wound dressing and process for its preparation
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
WO2006034249A2 (en) 2004-09-20 2006-03-30 Acrymed, Inc. Antimicrobial amorphous compositions
WO2007127236A2 (en) 2006-04-28 2007-11-08 Acrymed, Inc. Antimicrobial site dressings
US20100190004A1 (en) * 2008-11-24 2010-07-29 Gibbins Bruce L Antimicrobial laminate constructs
DE102010050311A1 (en) * 2010-11-03 2012-05-03 Bsn Medical Gmbh Wound dressing with a biocellulose layer that adsorbs bacteria
DE202018005661U1 (en) 2018-12-06 2019-01-14 Norbert Neubauer Sealing plaster for wounds

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035146A (en) * 1975-10-20 1977-07-12 Schwarz Services International Ltd. Binding of antimicrobial compounds to a hydroxyl containing substrate with cyanuric chloride
WO1980001041A1 (en) * 1978-11-17 1980-05-29 Smith & Nephew Res Adhesive-coated sheet material incorporating anti-bacterial substances
DE3033606A1 (en) * 1980-09-06 1982-04-08 B. Braun Melsungen Ag, 3508 Melsungen ANTI-ADHESIVE, ANTIMICROBIAL Wound Bandage AND METHOD FOR THE PRODUCTION THEREOF
DE3111336A1 (en) * 1980-04-15 1982-04-22 Chemiefaser Lenzing AG, 4860 Lenzing, Oberösterreich ASSOCIATION MATERIAL OR STITCHING PLASTER
DE3035037A1 (en) * 1980-09-17 1982-04-22 Fa. Carl Freudenberg, 6940 Weinheim Wound covering esp. as antiadhesive layer for absorbent dressings - comprises coated fibres in which pores of foamed coating contain wound healing promoting substances
DE3223851A1 (en) * 1981-06-25 1983-01-13 Napco, Inc., 06786 Terryville, Conn. DEVICE FOR GALVANIC COATING OF WORKPIECES
EP0136900A2 (en) * 1983-09-30 1985-04-10 JOHNSON & JOHNSON MEDICAL, INC. Antimicrobial fabric for surgical drape
EP0255248A2 (en) * 1986-07-24 1988-02-03 Minnesota Mining And Manufacturing Company Antimicrobial wound dressing
DE3635851A1 (en) * 1986-10-22 1988-05-05 Stieber Antriebselemente Gmbh Load balancing for non-return ratchets between the drives for a common conveying means
GB2202150A (en) * 1987-03-14 1988-09-21 Smith & Nephew Ass Adhesive dressings, their preparation and use
EP0296441A2 (en) * 1987-06-22 1988-12-28 Henkel Kommanditgesellschaft auf Aktien Use of insoluble, polyfunctional quaternary ammonium compounds for the adsorptive binding of microorganisms
WO1989002754A1 (en) * 1987-09-22 1989-04-06 Coloplast A/S A dressing material for the treatment of wounds, and corpuscles for use in the production thereof
EP0328421A2 (en) * 1988-02-11 1989-08-16 The Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
ATE52415T1 (en) * 1986-04-04 1990-05-15 Surgikos Inc ANTIMICROBIAL WOUND DRESSING OR MATERIAL FOR SURGICAL DRAPES.
US4929498A (en) * 1989-01-31 1990-05-29 James River Corporation Of Virginia Engineered-pulp wet wiper fabric
US4990144A (en) * 1986-08-20 1991-02-05 Smith And Nephew Associated Companies Plc Medicating impressed film wound dressing
DE4026153A1 (en) * 1990-08-17 1992-02-20 Sebapharma Gmbh & Co Wound bandage
EP0475807A2 (en) * 1990-08-30 1992-03-18 Terumo Kabushiki Kaisha Wound-covering materials
US5147338A (en) * 1981-02-13 1992-09-15 Smith And Nephew Associated Companies Limited Medicated, low adherency wound dressings
US5167613A (en) * 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
US5322695A (en) * 1987-01-09 1994-06-21 Hercon Laboratories Corporation Moisture-vapor-permeable dressing
EP0691133A1 (en) * 1994-07-05 1996-01-10 The Procter & Gamble Company Absorbent gelling material comprising a dry mixture of at least two types of hydrogel-forming particles and method for making the same
US5707736A (en) * 1991-04-04 1998-01-13 Sion Texo Medic Ltd. Products having anti-microbial activity
US5779736A (en) * 1995-01-19 1998-07-14 Eastman Chemical Company Process for making fibrillated cellulose acetate staple fibers
US5849311A (en) * 1996-10-28 1998-12-15 Biopolymerix, Inc. Contact-killing non-leaching antimicrobial materials

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB222150A (en) * 1923-09-20 1925-04-09 Vickers Electrical Co Ltd Improvements relating to receiving systems for electric signals
SE445013B (en) 1979-06-21 1986-05-26 Landstingens Inkopscentral Means for preventing or treating infections by humans and animals
DE3215134A1 (en) 1982-04-23 1983-10-27 The Washington Group, Inc., 27102 Winston-Salem, N.C. Antimicrobially treated textile article
DE3228851A1 (en) * 1982-08-02 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Wound dressing
SE460017B (en) 1984-03-14 1989-09-04 Landstingens Inkopscentral BACTERY-ADDRESSING COMPOSITION IN WATER-SOLUBLE FORM
DE3635453A1 (en) * 1986-08-07 1988-02-11 Hoechst Ag ANTIBACTERIAL ADHESIVE FILM
DE4218719A1 (en) * 1992-06-06 1993-12-09 Basf Ag Fast-spun threads based on polycaprolactam and process for their production
GB9411429D0 (en) * 1994-06-08 1994-07-27 Seton Healthcare Group Plc Wound dressings

Patent Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035146A (en) * 1975-10-20 1977-07-12 Schwarz Services International Ltd. Binding of antimicrobial compounds to a hydroxyl containing substrate with cyanuric chloride
WO1980001041A1 (en) * 1978-11-17 1980-05-29 Smith & Nephew Res Adhesive-coated sheet material incorporating anti-bacterial substances
DE3111336A1 (en) * 1980-04-15 1982-04-22 Chemiefaser Lenzing AG, 4860 Lenzing, Oberösterreich ASSOCIATION MATERIAL OR STITCHING PLASTER
DE3033606A1 (en) * 1980-09-06 1982-04-08 B. Braun Melsungen Ag, 3508 Melsungen ANTI-ADHESIVE, ANTIMICROBIAL Wound Bandage AND METHOD FOR THE PRODUCTION THEREOF
DE3035037A1 (en) * 1980-09-17 1982-04-22 Fa. Carl Freudenberg, 6940 Weinheim Wound covering esp. as antiadhesive layer for absorbent dressings - comprises coated fibres in which pores of foamed coating contain wound healing promoting substances
US5147338A (en) * 1981-02-13 1992-09-15 Smith And Nephew Associated Companies Limited Medicated, low adherency wound dressings
DE3223851A1 (en) * 1981-06-25 1983-01-13 Napco, Inc., 06786 Terryville, Conn. DEVICE FOR GALVANIC COATING OF WORKPIECES
EP0136900A2 (en) * 1983-09-30 1985-04-10 JOHNSON & JOHNSON MEDICAL, INC. Antimicrobial fabric for surgical drape
ATE52415T1 (en) * 1986-04-04 1990-05-15 Surgikos Inc ANTIMICROBIAL WOUND DRESSING OR MATERIAL FOR SURGICAL DRAPES.
EP0255248A2 (en) * 1986-07-24 1988-02-03 Minnesota Mining And Manufacturing Company Antimicrobial wound dressing
US4990144A (en) * 1986-08-20 1991-02-05 Smith And Nephew Associated Companies Plc Medicating impressed film wound dressing
DE3635851A1 (en) * 1986-10-22 1988-05-05 Stieber Antriebselemente Gmbh Load balancing for non-return ratchets between the drives for a common conveying means
US5322695A (en) * 1987-01-09 1994-06-21 Hercon Laboratories Corporation Moisture-vapor-permeable dressing
GB2202150A (en) * 1987-03-14 1988-09-21 Smith & Nephew Ass Adhesive dressings, their preparation and use
EP0296441A2 (en) * 1987-06-22 1988-12-28 Henkel Kommanditgesellschaft auf Aktien Use of insoluble, polyfunctional quaternary ammonium compounds for the adsorptive binding of microorganisms
WO1989002754A1 (en) * 1987-09-22 1989-04-06 Coloplast A/S A dressing material for the treatment of wounds, and corpuscles for use in the production thereof
EP0328421A2 (en) * 1988-02-11 1989-08-16 The Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US4929498A (en) * 1989-01-31 1990-05-29 James River Corporation Of Virginia Engineered-pulp wet wiper fabric
DE4026153A1 (en) * 1990-08-17 1992-02-20 Sebapharma Gmbh & Co Wound bandage
EP0475807A2 (en) * 1990-08-30 1992-03-18 Terumo Kabushiki Kaisha Wound-covering materials
US5395305A (en) * 1990-08-30 1995-03-07 Terumo Kabushiki Kaisha Multilayer wound covering materials comprising a supporting layer and a moisture permeation controlling layer and method for their manufacture
US5707736A (en) * 1991-04-04 1998-01-13 Sion Texo Medic Ltd. Products having anti-microbial activity
US5167613A (en) * 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
EP0691133A1 (en) * 1994-07-05 1996-01-10 The Procter & Gamble Company Absorbent gelling material comprising a dry mixture of at least two types of hydrogel-forming particles and method for making the same
US5779736A (en) * 1995-01-19 1998-07-14 Eastman Chemical Company Process for making fibrillated cellulose acetate staple fibers
US5849311A (en) * 1996-10-28 1998-12-15 Biopolymerix, Inc. Contact-killing non-leaching antimicrobial materials

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8118791B2 (en) 1995-09-05 2012-02-21 Argentum Medical, Llc Medical device
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US8283513B2 (en) 1995-09-05 2012-10-09 Argentum Medical, Llc Multilayer wound dressing
US8293964B2 (en) 1995-09-05 2012-10-23 Argentum Medical, Llc Multilayer laminate wound dressing
US8455710B2 (en) 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US7989674B2 (en) 1997-09-22 2011-08-02 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US8449514B2 (en) * 1997-09-22 2013-05-28 Argentum Medical, Llc Conductive wound dressings and methods of use
US8093444B2 (en) 1997-09-22 2012-01-10 Argentum Medical, Llc Multilayer conductive appliance having wound healing and analgesic properties
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US7709694B2 (en) 1998-12-08 2010-05-04 Quick-Med Technologies, Inc. Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces
US7045673B1 (en) 1998-12-08 2006-05-16 Quick-Med Technologies, Inc. Intrinsically bactericidal absorbent dressing and method of fabrication
US8318615B1 (en) * 1999-11-10 2012-11-27 Tri-Sis Inc. Launderable, leak-proof, breathable fabric and articles made therefrom
EP1450966A2 (en) * 2001-09-28 2004-09-01 Quick Med Technologies, Inc. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
EP1450966A4 (en) * 2001-09-28 2009-09-09 Quick Med Technologies Inc Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
WO2003039602A3 (en) * 2001-09-28 2003-10-30 Quick Med Technologies Inc Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
WO2003039602A2 (en) * 2001-09-28 2003-05-15 Quick Med Technologies, Inc. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US6712121B2 (en) 2001-10-12 2004-03-30 Kimberly-Clark Worldwide, Inc. Antimicrobially-treated fabrics
EP2371335A2 (en) 2002-10-23 2011-10-05 Tyco Healthcare Group LP Medical dressing containing antimicrobial agent
US8100872B2 (en) 2002-10-23 2012-01-24 Tyco Healthcare Group Lp Medical dressing containing antimicrobial agent
US20040082925A1 (en) * 2002-10-23 2004-04-29 Patel Harish A. Medical dressing containing antimicrobial agent
US9480770B2 (en) 2002-10-23 2016-11-01 Covidien Lp Methods for preparation of medical dressing containing antimicrobial agent
US8672906B2 (en) 2002-10-23 2014-03-18 Covidien LLP Medical dressing containing antimicrobial agent and related methods therefor
US20040092896A1 (en) * 2002-11-13 2004-05-13 Thompson Kaila R. Antimicrobial sheets for environmental and human protection
US20050037680A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Silver-containing wound care device
US20110040289A1 (en) * 2003-08-14 2011-02-17 Canada T Andrew Wound Care Device Having Fluid Transfer Properties
US8563447B2 (en) 2003-08-14 2013-10-22 Milliken & Company Silver-containing wound care device
US20050035327A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Topical silver-based antimicrobial composition for wound care devices
US20050037057A1 (en) * 2003-08-14 2005-02-17 Schuette Robert L. Silver-containing antimicrobial fabric
US7118761B2 (en) 2003-08-14 2006-10-10 Canada T Andrew Method for producing a silver-containing wound care device
US8394403B2 (en) 2003-08-14 2013-03-12 Milliken & Company Wound care device having fluid transfer properties
US20050147657A1 (en) * 2003-08-14 2005-07-07 Milliken & Company White silver-containing wound care device
US7842306B2 (en) 2003-08-14 2010-11-30 Milliken & Company Wound care device having fluid transfer properties
US8021685B2 (en) 2003-08-14 2011-09-20 Milliken + Co Wound care device having fluid transfer properties
US20060127462A1 (en) * 2003-08-14 2006-06-15 Canada T A Wound care device having fluid transfer properties
US7939686B2 (en) * 2004-02-25 2011-05-10 Supreme Corporation Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
US20050186259A1 (en) * 2004-02-25 2005-08-25 Uki Supreme Corporation Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
US20050214350A1 (en) * 2004-03-29 2005-09-29 Thompson Kaila R Antimicrobial sheets for environmental and human protection and prevention
US7576256B2 (en) 2004-12-10 2009-08-18 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition
US20060129080A1 (en) * 2004-12-10 2006-06-15 Bjornberg Sten G Wound dressing with a bacterial adsorbing composition
EP3061467A1 (en) 2004-12-10 2016-08-31 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition
US20070189214A1 (en) * 2006-01-18 2007-08-16 Samsung Electronics Co., Ltd. Apparatus and method for transmitting/receiving signal in a communication system
US20070255192A1 (en) * 2006-04-11 2007-11-01 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
US7750201B2 (en) 2006-04-11 2010-07-06 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
KR100791039B1 (en) 2006-07-28 2008-01-03 (재)대구경북과학기술연구원 Nano non-woven containing antioxidant for wound dressing and method for preparing thereof
EP2114470A4 (en) * 2007-01-18 2014-02-12 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
US10893981B2 (en) 2007-01-18 2021-01-19 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
EP2114470B1 (en) 2007-01-18 2018-03-07 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
US9463119B2 (en) 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
AU2008205695B2 (en) * 2007-01-18 2013-09-19 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
WO2008088281A1 (en) * 2007-01-18 2008-07-24 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
EP2114470A1 (en) * 2007-01-18 2009-11-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
US20110159051A1 (en) * 2007-05-01 2011-06-30 Taipei Veterans General Hospital Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof
US8470597B2 (en) * 2007-05-01 2013-06-25 Taipei Veterans General Hospital Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof
US20090131909A1 (en) * 2007-11-05 2009-05-21 Sten Bjornberg Device for the treatment of vaginal fungal infection
US8748689B2 (en) 2007-11-05 2014-06-10 Abigo Medical Ab Device for the treatment of vaginal fungal infection
EP3441054A1 (en) 2007-11-05 2019-02-13 Abigo Medical Ab Device for the treatment of vaginal fungal infection
US8460698B2 (en) 2008-08-01 2013-06-11 Milliken & Company Composite article suitable for use as a wound dressing
US20100030178A1 (en) * 2008-08-01 2010-02-04 Macmeccan Robert M Composite article suitable for use as a wound dressing
US20100055437A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
US20100062044A1 (en) * 2008-09-11 2010-03-11 Smith Jan G Method and a product to reduce and treat problems associated with tinea pedis
US8263115B2 (en) 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) * 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
US20100160853A1 (en) * 2008-12-03 2010-06-24 Smith Jan G Method for dressing a wound
EP2742921A1 (en) 2008-12-03 2014-06-18 Abigo Medical Ab Product for dressing a wound
US20140012102A1 (en) * 2012-09-11 2014-01-09 Zansors Llc Wearable patch comprising multiple separable adhesive layers
US10226216B2 (en) 2012-09-11 2019-03-12 Zansors Llc Wearable patch comprising multiple separable adhesive layers
US9629585B2 (en) * 2012-09-11 2017-04-25 Zansors Llc Wearable patch comprising multiple separable adhesive layers
US9393163B2 (en) * 2013-01-08 2016-07-19 Bsn Medical Gmbh Antimicrobially active wound dressing for catheter fixings
US9827397B2 (en) 2013-01-08 2017-11-28 Bsn Medical Gmbh Antimicrobially active wound dressing for catheter fixings
US20140194824A1 (en) * 2013-01-08 2014-07-10 Bsn Medical Gmbh Antimicrobially active wound dressing for catheter fixings
US10058455B2 (en) 2013-06-10 2018-08-28 Ultramend, Inc. Nano-enhanced wound dressing
US11844671B2 (en) 2013-06-10 2023-12-19 Ultramend, Inc. Nano-enhanced wound dressing
WO2016177663A1 (en) 2015-05-04 2016-11-10 Ime Gmbh Wound covering material
EP3090763A1 (en) 2015-05-04 2016-11-09 IME GmbH Wound covering material
US12006338B2 (en) 2019-10-18 2024-06-11 Topikos Scientific, Inc. Antimicrobial organosilanes
US12024533B2 (en) 2019-10-18 2024-07-02 Topikos Scientific, Inc. Antimicrobial organosilanes
CN110623791A (en) * 2019-10-30 2019-12-31 季华实验室 Fiber film layer and adhesive bandage with same

Also Published As

Publication number Publication date
DE19631421C2 (en) 2002-07-18
EP0826348A3 (en) 2000-03-22
DE19631421A1 (en) 1998-02-12
EP0826348A2 (en) 1998-03-04
AU3244597A (en) 1998-02-12
AU716910B2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
US6160196A (en) Antimicrobial wound coverings
AU2009331911B2 (en) Wound dressing
EP0219522B1 (en) Wound dressings
EP3061467B1 (en) Wound dressing with a bacterial adsorbing composition
US5976117A (en) Wound dressing
EP1638620B1 (en) Antimicrobial wounddressing
US6592888B1 (en) Composition for wound dressings safely using metallic compounds to produce anti-microbial properties
EP0218667B1 (en) Wound dressings
US9101682B2 (en) Antimicrobial composite
US5717005A (en) Adhesive compositions and products
JPH0233261B2 (en)
JPS5934263A (en) Protective material for adhesive wound
DK166066B (en) BACTERY-ADDRESSING PREPARATIONS IN VANDU-SOLUBLE FORM
GB2531345A (en) Composite wound dressing
US20060233888A1 (en) Silver coatings and methods of manufacture
JPH09327508A (en) Sheet material for medical treatment
JP4515794B2 (en) Wound pad
WO2012171920A1 (en) Treatment device
RU2129181C1 (en) Absorbing napkin
JP2005111205A (en) Wound dressing material
JP2010148916A (en) Pad for lesion
CA2042839A1 (en) Wound dressing and method for the production thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: BEIERSDORF AG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KNIELER, ROLAND;VON WOLFF, AXEL;REEL/FRAME:008756/0281

Effective date: 19970709

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: T J SMITH & NEPHEW LIMITED, ENGLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BEIERSDORF AG;REEL/FRAME:013343/0277

Effective date: 20020827

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20081212